Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

FDA To Investigate YAZ, Yasmin and Ocella

As a Texan YAZ, Yasmin, Ocella Dangerous Drug and Side Effect Attorney and medical doctor, we are in the process of evaluating, accepting and filing lawsuits against Bayer regarding the dangerous side effects of YAZ, Yasmin, Ocella oral contraceptives.


The Food and Drug Administration said it is conducting a safety review of certain types of drospirenone containing birth-control pills to see if they increase the risk of blood clots when compared to other older birth control pills.

The FDA said the review is focusing on products that contain drospirenone, which is used in pills including Yaz and Yasmin, which are marketed Bayer AG. Drospirenone is a type of female sex hormone called a progestin.

Most birth-control pills contain two types of hormones, estrogen and progestin. The FDA said two recently published studies reported a greater risk of blood clots for women taking birth-control pills containing drospirenone, compared to birth-control pills containing another progestin known as levonorgestrel.

The FDA said some previous studies have reported that the risk of blood clots for women who use birth-control pills containing drospirenone is higher than that for women who use birth-control pills containing levonorgestrel.

Blood clots form inside a vein, known as deep vein thrombosis, or DVT. The clots can break loose and travel to other areas of the body such as the lungs, known as pulmonary embolism, or PE.

The FDA said it is “currently evaluating the conflicting results from these studies and will look at all currently available information to fully assess the risks and benefits of drospirenone-containing birth-control pills.” An FDA-commissioned study involves more than 800,000 U.S. women and results are expected later this summer.

The European Medicines Agency said the risk of developing blood clots for oral contraceptives containing drospirenone was higher than that of pills containing levonorgestrel. EMA said the product labels of birth-control pills containing drospirenone will be updated.

The most recent studies were published earlier this year in the British Medical Journal. They compared women taking birth-control pills containing drospirenone with women taking birth-control pills containing levonorgestrel and found the risk of blood clots to be 2 to 3 times greater among women taking drospirenone products.

Information and commentary provided by Dallas Fort Worth Personal Injury Attorney Dr Shezad Malik. The Dr Shezad Malik Law Firm can be contacted in Dallas toll free at 888-210-9693. If you or a loved one has been injured from YAZ, YASMIN or OCELLA, please fill out our contact card for a free consultation.

Contact Information